Literature DB >> 16912532

[A case of unknown primary cancer responding to TS-1].

Kentaro Kawasaki1, Takashi Kamigaki, Shiro Takase, Keiko Maki, Takao Tamura, Daisuke Shirasaka, Hiroaki Shinoda, Tetsu Nakamura, Daisuke Kuroda, Yoshikazu Kuroda.   

Abstract

A 65-year-old male showed elevated tumor marker and intra-abdominal lymph node (LN) swelling. PET revealed an accumulation of FDG at para-aortic LNs from the mediastinum to the inguinal region. Although many different examinations were performed to detect primary cancer, none was found. We diagnosed unknown primary cancer (UPC), and administered TS-1 (100 mg/day). Six months later, the tumor marker lowered and the LN swelling reduced. PET showed a little accumulation of FDG at intra-abdominal LN. An intra-abdominal LN biopsy was performed, and an adenocarcinoma was seen at a lymph vessel. Then, 15 months later, brain metastasis was recognized and 18 months later the patient died of systematic metastasis. Autopsy was not performed, and primary cancer was not seen till the end. TS-1 proved effective for the UPC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912532

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Relapsed cervicomediastinal lymph node carcinoma with an unknown primary site treated with TS-1 alone: a case report.

Authors:  Toshiki Yajima; Ryoichi Onozato; Yoshinori Shitara; Akira Mogi; Shigebumi Tanaka; Hiroyuki Kuwano
Journal:  BMC Res Notes       Date:  2013-12-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.